With 44 million consumers banging on its door, and $950 million of revenue projected over the next three years, New Jersey’s adult use marijuana program is poised to define cannabis across the eastern seaboard.

Currently comprised of merely 95,000 patients and 12 alternative treatment centers (ATCs) to serve its 9,241,900 population, New Jersey’s decade-old medical marijuana program is both under performing and mired by ludicrous limitations and legal challenges.